ArticleCancer immunology research2024

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.

David A Knorr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.